MCM2-7

MCM2-7
Name	MCM2-7 complex
Gene	MCM2; MCM3; MCM4; MCM5; MCM6; MCM7
Organism	Homo sapiens
Function	DNA helicase, replication licensing

MCM2-7 MCM2-7 is a heterohexameric protein complex essential for eukaryotic DNA replication licensing and helicase activity. Discovered through studies in model organisms such as Saccharomyces cerevisiae, Xenopus laevis, and Drosophila melanogaster, the complex links origin recognition by ORC and activation by Cdc45 and GINS within the replicative machineries described across cell cycle research by groups at institutions like Cold Spring Harbor Laboratory and University of Cambridge.

Overview

The complex was characterized using biochemical purification and genetic screens in laboratories at Massachusetts Institute of Technology, European Molecular Biology Laboratory, and Max Planck Society affiliates, with foundational work referencing pioneers such as Bruce Stillman and John Diffley. Studies published in journals like Nature, Cell, and Science established MCM2-7 as the core of replication forks studied alongside proteins from Cyclin-dependent kinase (CDK) pathways, Dbf4-dependent kinase (DDK), and checkpoints regulated by ATR and ATM kinases. Comparative genomics projects at NCBI and Ensembl mapped MCM orthologs across taxa including Arabidopsis thaliana, Caenorhabditis elegans, and Mus musculus.

Structure and subunit composition

The six distinct subunits—encoded by paralogous genes identified by sequencing centers such as Sanger Institute—assemble into a ring-shaped hexamer with AAA+ ATPase domains, as revealed by cryo-electron microscopy studies performed at European Synchrotron Radiation Facility and EMBL Heidelberg. Structural biology efforts from groups at Max Planck Institute for Biophysical Chemistry and University of California, San Francisco resolved nucleotide-binding pockets and intersubunit interfaces, informing mutational analyses first reported by teams at Harvard Medical School and Johns Hopkins University School of Medicine. The architecture positions MCM2, MCM3, MCM4, MCM5, MCM6, and MCM7 in a defined order, comparable to assemblies examined in archaea and linked to ATP hydrolysis cycles studied in laboratories at Institute of Molecular Biology (IME). Crosslinking mass spectrometry by facilities at Broad Institute and Stanford University delineated contact maps between subunits and accessory factors.

Role in DNA replication and helicase activity

MCM2-7 functions as the catalytic core of the replicative helicase, unwinding duplex DNA at replication forks during S phase, integrating activation signals from Cdc7-Dbf4 and recruitment factors including Mcm10 and Sld3. Biochemical assays performed by teams at University of Oxford and Technische Universität München reconstituted helicase activity with Cdc45 and GINS to form the active CMG helicase, demonstrating translocation on single-stranded DNA and coupling to leading-strand polymerases such as DNA polymerase ε and lagging-strand polymerases like DNA polymerase δ. Cell cycle synchronization studies using methods developed at University of Chicago and checkpoint research from Fred Hutchinson Cancer Center showed interplay with Wee1 and Cdc25 regulators.

Regulation and post-translational modifications

Regulatory phosphorylation by kinases including Cyclin-dependent kinase 2 (CDK2), Cdc7-Dbf4 (DDK), ATR, and ATM modulates loading, activation, and stability; these modifications were mapped by phosphoproteomics at Proteomics Core Facility, EMBL and analyzed in proteome studies at European Bioinformatics Institute. SUMOylation, ubiquitination by ligases such as SCF (Skp, Cullin, F-box complex) components, and acetylation events reported from work at Yale School of Medicine and University of Tokyo further influence chromatin association and turnover. Proteostasis pathways involving p97/VCP and the ubiquitin–proteasome system mediate removal of aberrant complexes, as shown in mechanistic studies from Cold Spring Harbor Laboratory and MIT Koch Institute.

Interactions and complex formation (CMG and replisome)

Activation entails conversion of the double-hexamer loaded at origins into single hexameric CMG (Cdc45–MCM–GINS) helicase, a process elucidated by structural and single-molecule analyses at Max Planck Institute for Biochemistry and Lawrence Berkeley National Laboratory. The replisome assembles incorporating factors such as Replication protein A (RPA), PCNA, RFC complex, Mcm10, And-1/Ctf4, and DNA polymerases whose interactions were mapped by labs at University of California, Berkeley and Columbia University. Chromatin context modulators including Histone H3 variants and remodeling complexes like SWI/SNF influence recruitment, described in epigenetics studies at Rockefeller University and Broad Institute. Interplay with checkpoint mediators Rad9-Rad1-Hus1 (9-1-1) complex integrates replication stress responses characterized in teams at Salk Institute.

Implications in disease and clinical significance

Dysregulation, mutation, or altered expression of subunits has been implicated in genomic instability, proliferative disorders, and cancer types profiled by The Cancer Genome Atlas (TCGA) and analyzed in clinical cohorts at Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center. Overexpression correlates with prognosis markers studied in breast cancer and colorectal cancer cohorts, and loss-of-function mutations affect development in model organisms examined at Wellcome Sanger Institute. Small-molecule inhibitors targeting helicase activation pathways and DDK are under investigation by pharmaceutical groups including teams at Novartis and GlaxoSmithKline with preclinical models run at Howard Hughes Medical Institute-affiliated labs. Biomarker studies leveraging next-generation sequencing platforms from Illumina and proteomic signatures from Thermo Fisher Scientific aim to exploit MCM-related vulnerabilities for diagnostics and therapeutics.

Category:DNA replication proteins